Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Pietro Spada"'
Publikováno v:
IEEE Access, Vol 12, Pp 141237-141250 (2024)
LoRaWAN is a Low Power infrastructure for the Internet of Things (IoT) with a centralized architecture where a single node, the network server, handles all data collection and network management decisions. Given the proliferation and widespread adopt
Externí odkaz:
https://doaj.org/article/11fce8750cde4d109170bd282da3e9c1
Autor:
Maria Rosaria Valerio, Pietro Spadaro, Concetta Arcanà, Nicolò Borsellino, Calogero Cipolla, Paolo Vigneri, Dario Piazza, Vittorio Gebbia
Publikováno v:
Future Science OA, Vol 7, Iss 10 (2021)
A retrospective analysis of 70 patients with triple-negative or hormone-resistant advanced breast carcinoma who had not previously received chemotherapy was carried out. Patients received oral vinorelbine 60 mg/m2 on day 1 and 8, plus capecitabine 10
Externí odkaz:
https://doaj.org/article/da93e496c4ea43c8a2d8f62f60f5ed76
Publikováno v:
Sensors, Vol 22, Iss 7, p 2470 (2022)
The large development of Internet of Things technologies is increasing the use of smart-devices to solve and support several real-life issues. In many cases, the aim is to move toward systems that, even if significant demands are not required in term
Externí odkaz:
https://doaj.org/article/2e16ae85ca06414bbcc604d9745b6d4f
Autor:
Robert Anderson, null Spontini, null Soloists, Chorus, amp &, null Orchestra of La Scala, Riccardo Muti, null Mercadante, Geoffrey Mitchell Choir, Philharmonia Orchestra, David Parry, null The Philharmonia Soloists, Pietro Spada
Publikováno v:
The Musical Times. 137:30
Publikováno v:
The Musical Times. 136:313
Autor:
Vincenzo Adamo, Giuseppina Rosaria Rita Ricciardi, Dario Giuffrida, Giuseppa Scandurra, Antonio Russo, Livio Blasi, Pietro Spadaro, Carmelo Iacono, Hector J. Soto Parra, Antonino Savarino, Francesco Ferraú, Filippo Zerilli, Francesco Verderame, Alfredo Butera, Carlo Santangelo, Veronica Franchina, Michele Caruso
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 11 (2019)
Background: In real-world practice, eribulin mesylate provides significant survival benefit, with a manageable safety profile in heavily pretreated patients with metastatic breast cancer (MBC). Methods: In this prospective, open-label, multicentre, o
Externí odkaz:
https://doaj.org/article/0cb949d87d9b4574863b63a96c3a26c0
Publikováno v:
Notes. 41:595
Publikováno v:
The Musical Times. 123:342
Publikováno v:
Notes. 35:432